Innoviva, Inc. (INVA) stock
INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3039% below fair value
$18.40+0.10 (+0.55%)
Close on Nov 18, 2026Market cap $1.33BP/E 9.3Yield –
Innoviva market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Innoviva's market cap was $1.37B on Nov 11, 2026, against $1.62B a year earlier. Over the last 5 years it ranged from $778.37M to $1.74B, with a median of $1.14B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.37B | -8.3% |
| 2025 | Dec 31, 2025 | $1.49B | +37.6% |
| 2024 | Dec 31, 2024 | $1.09B | +5.2% |
| 2023 | Dec 29, 2023 | $1.03B | +11.7% |
| 2022 | Dec 30, 2022 | $924.53M | -22.9% |
| 2021 | Dec 31, 2021 | $1.20B | -4.6% |
| 2020 | Dec 31, 2020 | $1.26B | -12.4% |
| 2019 | Dec 31, 2019 | $1.43B | -28.4% |
| 2018 | Dec 31, 2018 | $2.00B | +8.9% |
| 2017 | Dec 29, 2017 | $1.84B | +44.9% |
| 2016 | Dec 30, 2016 | $1.27B | +4.8% |
| 2015 | Dec 31, 2015 | $1.21B | -22.6% |
| 2014 | Dec 31, 2014 | $1.57B | -60.3% |
| 2013 | Dec 31, 2013 | $3.94B | +81.1% |
| 2012 | Dec 31, 2012 | $2.18B | +36.6% |
| 2011 | Dec 30, 2011 | $1.59B | +0.8% |
| 2010 | Dec 31, 2010 | $1.58B | – |
See a number that looks wrong?